The researching of cause and effect of rare diseases is relatively unimportant to the vast population. Some may even say that it is considered a waste of taxpayer’s money, but when you ask those individuals, who are suffering with a rare disease you will receive a different response.
The issue of health care is important to every individual, but those who suffer with rare diseases are pushed to the sidelines and left to flounder and take care of themselves best they are able. The main difficulty is there is no interest or money to fund the research for rare diseases.
However, the health insurance industry has begun to take an interest in rare diseases because they are beginning to understand how it leads to other known illnesses. The illnesses that develop from a rare disease can be very costly when it leads to other diseases and illnesses.
The medical health care community has finally acknowledged this connection and the health insurance industry is beginning to realize how cost effective it will be in the end if a cure or a treatment plan can be sustained. This of course brings renewed hope for those in our population who are silently suffering from one or more rare diseases that have been identified.
Sadly, in many cases those suffering from any number of known rare diseases will ultimately lose their life because there was no help for them. The toll in human life is extensive when a little health care assistance from a trained medical health care provider could have made the difference.
When those who suffer from rare diseases are helped through a trained medical health care provider, they have a much better opportunity of being a productive citizen and easing the burden on the community and overall health care community. Health insurance providers will find it much easier to offer affordable health insurance and will ultimately increase their base line.
Now that the medical health care community is beginning to recognize the connection between rare diseases and known diseases, the possibility of future funding seems to be much brighter than it ever has been in the past. This may even help the health insurance providers to reassess the list they current maintain of pre-existing conditions when they learn how many of them begin.
Individuals today suffering from any number of the known seven thousand rare diseases will find this study to be one of fascination and hope. By discussing these options with their health care provider, they will be taking a step in the right direction.